The multifactorial influence of PINK1/Parkin in promoting neuronal survival, the prevalence of PINK1 and PRKN mutations in PD, and the well-resolved molecular details of the PINK1/Parkin mitophagy pathway, have prompted a focus on targeting this pathway to treat PD. This evidence concerns the gene PINK1 and Parkinson disease.